The use of hormone alternative remedy (HRT) to ease the results of menopause has been related to a better danger of dementia, a brand new research has discovered - however the hyperlink between the 2 will not be all the way down to the therapy.

The nationwide research from Denmark, revealed within the British Medical Journal, seems to contradict some earlier research that advised HRT protects in opposition to cognitive decline if remedies are began close to the onset of menopause.

But it was difficult by the truth that scientists couldn't distinguish the explanations HRT was prescribed within the first place - to deal with modifications in sleep, temper, reminiscence, and pondering - from the early signs of dementia.

Therefore, in a number of the ladies handled with HRT within the research, signs that prompted the remedy may very well have mirrored early neurological modifications that might have led to a dementia prognosis anyway.

Dr Sarah-Naomi James of the MRC Unit for Lifelong Health and Ageing at University College London, who was not concerned within the Danish analysis, stated the research "has fundamental limitations" in its capacity to interpret the hyperlink between HRT and dementia, given the similarities between causes for prescribing HRT and early signs of dementia.

"This new study alone should not change practice," Dr James stated in an announcement.

For the research, researchers tracked greater than 60,000 Danish ladies, together with 5,589 who developed dementia.

Nearly 18,000 had obtained HRT with a mix of estrogen and progestin, with half beginning therapy earlier than age 53 and half stopping inside 4 years. Roughly 90% used oral drugs.

Compared with ladies who by no means used HRT, those that did had a 24% increased danger of an eventual dementia prognosis.

The danger elevated with the length of therapy, reaching 74% for individuals who took HRT for greater than 12 years.

About 15% of girls aged 45 to 64 in England are at present prescribed HRT, based on Department of Health figures.

HRT's hyperlinks to dementia

HRT was extensively prescribed earlier than 2003 when a big, randomised, trial discovered it was linked with a two-fold enhance within the danger of dementia in ladies older than 65.

But subsequent research discovered no enhance when HRT was began between the ages of fifty and 55, or shortly after menopause.

Read extra:HRT subscription limited to two months amid demand strugglesYear's supply of HRT to cost under £20Symptoms 'forcing one in 10 women to quit job'

But on this new research, the hyperlink between HRT use and dementia endured no matter when therapy began.

"The observed associations could be artefactual and should not be used to infer a causal relationship between hormone therapy and dementia risk" or to assist docs and sufferers make choices about utilizing HRT, the authors of the research stated.

Study chief Dr Amani Meaidi of the Danish Cancer Society Research Center in Copenhagen stated whereas the research can't show HRT contributes to dementia, causality "is biologically plausible," and additional analysis is required.

The advantages of HRT

In the meantime, because of well-known opposed results of HRT, together with elevated dangers of most cancers and blood clots, specialists in Denmark advise ladies with menopausal signs to first attempt life-style interventions equivalent to train, minimising alcohol and caffeine use, not smoking, and sustaining a wholesome weight, Dr Meaidi stated.

If life-style modifications don't assist and there are not any medical causes to keep away from HRT, docs are suggested to prescribe hormone remedy with the shortest length and the smallest dose potential, she stated.

The Menopause Charity says body-identical HRT has already been proven to assist scale back the long-term danger for ladies of osteoporosis, coronary heart illness, and even colon most cancers.

Click to subscribe to the Sky News Daily wherever you get your podcasts

Other analysis from the US discovered that "women who took transdermal, body-identical estrogen and progesterone were 73% less likely to get dementia and other brain-degenerating diseases".

The charity referred to as this an "amazing and heartening figure" as a result of two out of three Alzheimer's sufferers are feminine.